Global Polio Vaccine
Market Report
2025
Delivery Includes:- Market Timeline 2021 till 2033, Market Size, Revenue/Volume Share, Forecast and CAGR, Competitor Analysis, Regional Analysis, Country Analysis, Segment Analysis, Market Trends, Drivers, Opportunities, Restraints, ESG Analysis, Porters Analysis, PESTEL Analysis, Market Attractiveness, Patent Analysis, Technological Trend, SWOT Analysis, COVID-19 Analysis, Consumer Behavior Analysis, etc.
The base year for the calculation is 2024. The historical will be 2021 to 2024. The year 2025 will be estimated one while the forecasted data will be from year 2025 to 2033. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Polio Vaccine Market Report 2025.
"Global Polio Vaccine market size 2025 is $887 Million whereas according out published study it will reach to $1204.61 Million by 2033. Polio Vaccine market will be growing at a CAGR of 3.9% during 2025 to 2033."
As per the current market study, out of 887 Million USD global market revenue 2025, North America market holds 25.60% of the market share. The North America Polio Vaccine industry grew from 200.94 Million USD in 2021 to 227.072 Million USD in 2025 and will record 88.49% growth. In coming future this industry will reach 297.54 Million by 2033 with a 3.436% CAGR. If we look at the percentage market shares of top North America countries for 2025,Mexico (7.10%), Canada (13.54%), United States (79.36%)
As per the current market study, out of 887 Million USD global market revenue 2025, Europe market holds 22.00% of the market share. The Europe Polio Vaccine industry grew from 172.016 Million USD in 2021 to 195.14 Million USD in 2025 and will record 88.15% growth. In coming future this industry will reach 261.401 Million by 2033 with a 3.722% CAGR. If we look at the percentage market shares of top Europe countries for 2025,Sweden (5.10%), Germany (17.40%), Spain (6.60%), United Kingdom (11.60%), Luxembourg (3.10%), Russia (12.10%), Switzerland (4.30%), Italy (5.00%), Denmark (4.70%), France (10.40%), Rest of Europe (19.70%)
As per the current market study, out of 887 Million USD global market revenue 2025, Asia Pacific market holds 36.90% of the market share. The Asia Pacific Polio Vaccine industry grew from 279.336 Million USD in 2021 to 327.303 Million USD in 2025 and will record 85.34% growth. In coming future this industry will reach 466.186 Million by 2033 with a 4.52% CAGR. If we look at the percentage market shares of top Asia Pacific countries for 2025,South East Asia (15.37%), Japan (10.86%), Singapore (2.80%), China (38.80%), Australia (2.33%), South Korea (5.00%), Taiwan (3.00%), India (19.10%), Rest of APAC (2.74%)
As per the current market study, out of 887 Million USD global market revenue 2025, South America market holds 6.90% of the market share. The South America Polio Vaccine industry grew from 44.907 Million USD in 2021 to 61.203 Million USD in 2025 and will record 73.37% growth. In coming future this industry will reach 84.323 Million by 2033 with a 4.087% CAGR. If we look at the percentage market shares of top South America countries for 2025,Peru (5.50%), Colombia (8.30%), Argentina (11.30%), Brazil (35.30%), Chile (5.00%), Rest of South America (34.60%)
As per the current market study, out of 887 Million USD global market revenue 2025, Middle East market holds 5.40% of the market share. The Middle East Polio Vaccine industry grew from 41.101 Million USD in 2021 to 47.898 Million USD in 2025 and will record 85.81% growth. In coming future this industry will reach 59.026 Million by 2033 with a 2.646% CAGR. If we look at the percentage market shares of top Middle East countries for 2025,Saudi Arabia (41.40%), Qatar (8.64%), Egypt (11.30%), UAE (11.56%), Turkey (22.30%), Rest of Middle East (4.80%)
As per the current market study, out of 887 Million USD global market revenue 2025, Africa market holds 3.20% of the market share. The Africa Polio Vaccine industry grew from 22.834 Million USD in 2021 to 28.384 Million USD in 2025 and will record 80.45% growth. In coming future this industry will reach 36.138 Million by 2033 with a 3.065% CAGR. If we look at the percentage market shares of top Africa countries for 2025,South Africa (42.50%), Nigeria (25.20%), Rest of Africa (32.30%)
2021 | 2025 | 2033 | CAGR | |
---|---|---|---|---|
Global Polio Vaccine Market Sales Revenue | $ 761.135 Million | $ 887 Million | $ 1204.61 Million | 3.9% |
North America Polio Vaccine Market Sales Revenue | $ 200.94 Million | $ 227.072 Million | $ 297.54 Million | 3.436% |
Mexico Polio Vaccine Market Sales Revenue | $ 13.865 Million | $ 16.122 Million | $ 21.423 Million | 3.617% |
Canada Polio Vaccine Market Sales Revenue | $ 26.805 Million | $ 30.746 Million | $ 41.477 Million | 3.813% |
United States Polio Vaccine Market Sales Revenue | $ 160.269 Million | $ 180.204 Million | $ 234.64 Million | 3.355% |
Europe Polio Vaccine Market Sales Revenue | $ 172.016 Million | $ 195.14 Million | $ 261.401 Million | 3.722% |
Sweden Polio Vaccine Market Sales Revenue | $ 9.117 Million | $ 9.952 Million | $ 12.547 Million | 2.939% |
Germany Polio Vaccine Market Sales Revenue | $ 29.071 Million | $ 33.954 Million | $ 47.052 Million | 4.162% |
Spain Polio Vaccine Market Sales Revenue | $ 11.869 Million | $ 12.879 Million | $ 16.991 Million | 3.524% |
United Kingdom Polio Vaccine Market Sales Revenue | $ 19.61 Million | $ 22.636 Million | $ 30.845 Million | 3.944% |
Luxembourg Polio Vaccine Market Sales Revenue | $ 5.677 Million | $ 6.049 Million | $ 7.842 Million | 3.298% |
Russia Polio Vaccine Market Sales Revenue | $ 21.502 Million | $ 23.612 Million | $ 29.8 Million | 2.952% |
Switzerland Polio Vaccine Market Sales Revenue | $ 7.741 Million | $ 8.391 Million | $ 10.717 Million | 3.106% |
Italy Polio Vaccine Market Sales Revenue | $ 9.289 Million | $ 9.757 Million | $ 11.894 Million | 2.506% |
Denmark Polio Vaccine Market Sales Revenue | $ 8.257 Million | $ 9.172 Million | $ 12.024 Million | 3.443% |
France Polio Vaccine Market Sales Revenue | $ 18.406 Million | $ 20.295 Million | $ 25.879 Million | 3.085% |
Rest of Europe Polio Vaccine Market Sales Revenue | $ 31.479 Million | $ 38.443 Million | $ 55.809 Million | 4.77% |
Asia Pacific Polio Vaccine Market Sales Revenue | $ 279.336 Million | $ 327.303 Million | $ 466.186 Million | 4.52% |
South East Asia Polio Vaccine Market Sales Revenue | $ 42.375 Million | $ 50.306 Million | $ 67.783 Million | 3.798% |
Japan Polio Vaccine Market Sales Revenue | $ 31.453 Million | $ 35.545 Million | $ 48.763 Million | 4.031% |
Singapore Polio Vaccine Market Sales Revenue | $ 8.38 Million | $ 9.164 Million | $ 12.121 Million | 3.557% |
China Polio Vaccine Market Sales Revenue | $ 107.545 Million | $ 126.994 Million | $ 188.339 Million | 5.05% |
Australia Polio Vaccine Market Sales Revenue | $ 7.067 Million | $ 7.626 Million | $ 9.93 Million | 3.354% |
South Korea Polio Vaccine Market Sales Revenue | $ 15.364 Million | $ 16.365 Million | $ 20.512 Million | 2.864% |
Taiwan Polio Vaccine Market Sales Revenue | $ 8.939 Million | $ 9.819 Million | $ 13.053 Million | 3.623% |
India Polio Vaccine Market Sales Revenue | $ 51.677 Million | $ 62.515 Million | $ 92.305 Million | 4.992% |
Rest of APAC Polio Vaccine Market Sales Revenue | $ 6.536 Million | $ 8.968 Million | $ 13.38 Million | 5.128% |
South America Polio Vaccine Market Sales Revenue | $ 44.907 Million | $ 61.203 Million | $ 84.323 Million | 4.087% |
Peru Polio Vaccine Market Sales Revenue | $ 2.56 Million | $ 3.366 Million | $ 4.469 Million | 3.606% |
Colombia Polio Vaccine Market Sales Revenue | $ 3.682 Million | $ 5.08 Million | $ 7.083 Million | 4.243% |
Argentina Polio Vaccine Market Sales Revenue | $ 5.209 Million | $ 6.916 Million | $ 9.157 Million | 3.572% |
Brazil Polio Vaccine Market Sales Revenue | $ 15.717 Million | $ 21.605 Million | $ 30.188 Million | 4.27% |
Chile Polio Vaccine Market Sales Revenue | $ 2.335 Million | $ 3.06 Million | $ 4.132 Million | 3.825% |
Rest of South America Polio Vaccine Market Sales Revenue | $ 15.403 Million | $ 21.176 Million | $ 29.294 Million | 4.14% |
Middle East Polio Vaccine Market Sales Revenue | $ 41.101 Million | $ 47.898 Million | $ 59.026 Million | 2.646% |
Saudi Arabia Polio Vaccine Market Sales Revenue | $ 16.81 Million | $ 19.83 Million | $ 24.366 Million | 2.608% |
Qatar Polio Vaccine Market Sales Revenue | $ 3.428 Million | $ 4.138 Million | $ 5.159 Million | 2.793% |
Egypt Polio Vaccine Market Sales Revenue | $ 4.562 Million | $ 5.412 Million | $ 6.788 Million | 2.871% |
UAE Polio Vaccine Market Sales Revenue | $ 4.71 Million | $ 5.537 Million | $ 7.024 Million | 3.018% |
Turkey Polio Vaccine Market Sales Revenue | $ 9.33 Million | $ 10.681 Million | $ 12.986 Million | 2.472% |
Rest of Middle East Polio Vaccine Market Sales Revenue | $ 2.261 Million | $ 2.299 Million | $ 2.703 Million | 2.046% |
Africa Polio Vaccine Market Sales Revenue | $ 22.834 Million | $ 28.384 Million | $ 36.138 Million | 3.065% |
South Africa Polio Vaccine Market Sales Revenue | $ 9.796 Million | $ 12.063 Million | $ 15.178 Million | 2.913% |
Nigeria Polio Vaccine Market Sales Revenue | $ 5.709 Million | $ 7.153 Million | $ 9.251 Million | 3.268% |
Rest of Africa Polio Vaccine Market Sales Revenue | $ 7.33 Million | $ 9.168 Million | $ 11.709 Million | 3.105% |
Base Year | 2024 |
Historical Data Time Period | 2021-2024 |
Forecast Period | 2025-2033 |
Market Split by Type |
|
Market Split by By Application |
|
Market Split by By End User |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Report scope is customizable as we have a huge database of Polio Vaccine industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Polio Vaccine Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Market Dynamics such as Drivers, Restraints, Opportunities, Trends data
The pharmaceutical and healthcare industry is expanding rapidly, driven by an aging global population, increasing prevalence of chronic diseases, and rising healthcare expenditure. Investments in precision medicine, gene therapy, and digital health are reshaping the industry, improving patient outcomes and reducing costs.
However, the industry faces challenges such as high drug development costs, strict regulatory requirements, and pricing pressures. Despite these challenges, emerging markets in Asia-Pacific, Latin America, and the Middle East offer significant growth opportunities, driven by improving healthcare infrastructure and rising disposable income.
Key trends shaping the industry include the adoption of artificial intelligence (AI) and machine learning (ML) for personalized medicine, telemedicine, and digital health. Sustainability and eco-friendly pharmaceutical solutions are also gaining traction, driven by regulatory demands for greater environmental responsibility.
We have various report editions of Polio Vaccine Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
The reintroduction of tariffs under President Trump’s “Liberation Day Tariffs” in April 2025 has created significant disruption in global pharmaceutical trade. These tariffs, ranging from 10% to 46%, specifically target pharmaceutical products, APIs (active pharmaceutical ingredients), medical packaging, and machinery from key manufacturers in China and India. This has led to increased production costs, supply chain delays, and regulatory challenges for U.S.-based pharmaceutical companies.
The tariffs have particularly impacted generic drug manufacturers, who rely heavily on APIs from China and India. Biopharmaceuticals and vaccines are also feeling the pressure, with tariffs on critical materials like bioproduction media and cold-chain packaging raising costs by up to 25%. Similarly, contract manufacturing organizations (CMOs) are grappling with the need to identify new suppliers and adjust production plans to mitigate rising costs.
Foreign governments, including the European Union, have retaliated with tariffs on U.S. pharmaceutical exports, further complicating global trade. Clinical trials are also impacted, as tariffs on drugs and diagnostic kits delay trial timelines.
Market research is increasingly crucial for navigating these challenges. By providing real-time data on API pricing, supplier reliability, and tariff impact, pharmaceutical firms can make informed decisions on sourcing, compliance, and investment strategies. This data-driven approach helps mitigate risks, optimize supply chains, and identify alternative manufacturing hubs to offset tariff-related disruptions.
Overall, market research is essential for pharmaceutical companies to adapt to the new tariff landscape, enabling them to maintain competitive advantage and navigate global trade dynamics effectively.
The pharmaceutical and healthcare industry is highly competitive, with key players expanding their portfolios through new product launches, mergers and acquisitions, strategic partnerships, and regulatory approvals.
Financial performance metrics include revenue, gross margin, and market share, as well as SWOT analysis for key players. The report also evaluates companies' responses to COVID-19 challenges, including supply chain adjustments and investments in digital healthcare solutions.
The market size is projected based on global, regional, and country-level demand patterns, with research including value chain analysis, patent analysis, and competitive matrix. This comprehensive study serves as a vital resource for investors, industry stakeholders, and businesses navigating the evolving pharmaceutical and healthcare landscape.
Top Companies Market Share in Polio Vaccine Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
Region and country analysis section of Polio Vaccine Industry Analysis has been segmented into 5 major region such as North America, Europe, Asia Pacific, Middle East & Africa ,and Latin America (along with respective major contributing countries) and provides the revenue share, current trends.
The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of Polio Vaccine market.
The current report Scope analyzes Polio Vaccine Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Global Polio Vaccine Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Polio Vaccine Industry growth. Polio Vaccine market has been segmented with the help of its Type, By Application By End User , and others. Polio Vaccine market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
This report categorizes competitors in the pharmaceutical and healthcare market based on their product offerings and business models. It includes key details such as definitions, benefits, applications, technological advancements, and regional advantages for each type of pharmaceutical product, including small molecule drugs, biologics, and biosimilars.
Market growth figures, such as market share percentages, revenue, and growth rates (e.g., CAGR), are provided for each segment over the specified period (2019-2023). The report covers various segments
Type of Polio Vaccine analyzed in this report are as follows:
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Polio Vaccine Industry. Request a Free Sample PDF!
This report analyzes revenue growth in the pharma and healthcare industry at global, regional, and national levels, highlighting trends and opportunities for each application. It explores how sectors like pharmaceuticals, therapy, and healthcare monitoring use innovations to address healthcare needs. Key factors include market size, revenue contributions, technological advancements (e.g., AI-driven diagnostics), and regulatory considerations. The report also covers the value chain, identifying key players and processes within the industry. For more information, please request a sample or contact our research team.
Some of the key By Application of Polio Vaccine are:
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Senior Research Associate at Cognitive Market Research
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over three years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies.
In her current role, Manjiri handles the market research related to Pharma and healthcare industry. Her passion lies in utilizing innovative approaches to distill complex information into strategic insights that empower organizations to make informed decisions.Manjiri remains an invaluable asset in the dynamic landscape of market research.
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Polio Vaccine Market is witnessing significant growth in the near future.
In 2023, the Inactivated Polio vaccine segment accounted for noticeable share of global Polio Vaccine Market and is projected to experience significant growth in the near future.
The Public segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Astellas Pharma , Emergent BioSolutions and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Disclaimer:
Type | Inactivated Polio vaccine, Oral Polio Vaccine |
By Application | Public, Private |
By End User | Hospitals & Clinics, Public Services, Others |
List of Competitors | Astellas Pharma, CSL Limited, Emergent BioSolutions, GlaxoSmithKline, Johnson&Johnson, MedImmune, Merck, Others |
This chapter will help you gain GLOBAL Market Analysis of Polio Vaccine. Further deep in this chapter, you will be able to review Global Polio Vaccine Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Polio Vaccine. Further deep in this chapter, you will be able to review North America Polio Vaccine Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Polio Vaccine. Further deep in this chapter, you will be able to review Europe Polio Vaccine Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Polio Vaccine. Further deep in this chapter, you will be able to review Asia Pacific Polio Vaccine Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Polio Vaccine. Further deep in this chapter, you will be able to review South America Polio Vaccine Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
This chapter will help you gain Middle East Market Analysis of Polio Vaccine. Further deep in this chapter, you will be able to review Middle East Polio Vaccine Market Split by various segments and Country Split.
Chapter 6 Middle East Market Analysis
This chapter will help you gain Middle East Market Analysis of Polio Vaccine. Further deep in this chapter, you will be able to review Middle East Polio Vaccine Market Split by various segments and Country Split.
Chapter 7 Africa Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Polio Vaccine. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
Segmentation Type Analysis 2019 -2031, will provide market size split by Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Type Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by By Application Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by By End User Analysis 2021 - 2033
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Polio Vaccine market
Chapter 13 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Chapter 14 Research Methodology and Sources
Why Inactivated Polio vaccine have a significant impact on Polio Vaccine market? |
What are the key factors affecting the Inactivated Polio vaccine and Oral Polio Vaccine of Polio Vaccine Market? |
What is the CAGR/Growth Rate of Public during the forecast period? |
By type, which segment accounted for largest share of the global Polio Vaccine Market? |
Which region is expected to dominate the global Polio Vaccine Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|